VarCov Co’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
Other funds holding SYRE
VarCov Co's SYRE Position: Q3 2026 in Review
VarCov Co sold out of Spyre Therapeutics (SYRE) in Q3 2026, closing a stake of 2,895 shares — an estimated $257K sold.
VarCov Co first reported a position in SYRE in Q4 2025 and held it in 2 quarters. The position peaked at $262K in Q4 2025. 286 funds tracked by Wall St. Rank hold SYRE as of Q3 2026.
- VarCov Co reported no remaining Spyre Therapeutics position as of Q3 2026 after selling out during the quarter.
- VarCov Co sold 2,895 Spyre Therapeutics shares in Q3 2026, an estimated $257K.
- VarCov Co first reported a position in Spyre Therapeutics in Q4 2025 and held it in 2 quarters.
- VarCov Co's Spyre Therapeutics position peaked at $262K in Q4 2025.
- 286 funds tracked by Wall St. Rank held Spyre Therapeutics as of Q3 2026.
Based on VarCov Co's 13F filing for Q3 2026, filed 16 Nov 2026.